Cardiac troponin I in feline hypertrophic cardiomyopathy

Journal of Veterinary Internal Medicine

Volumn 16, Issue 5, 2002, Pages 558-564

  Herndon, William E ^a   Kittleson, Mark D ^b   Sanderson, Karen ^b   Drobatz, Kenneth J ^a   Clifford, Craig A ^a   Gelzer, Anna ^a,c   Summerfield, Nuala J ^a   Linde, Annika ^a   Sleeper, Meg M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Animal Health Diagnostic Center   (United States)

Author keywords

Congestive heart failure; Ischemia; Protein

Indexed keywords

BIOLOGICAL MARKER; TROPONIN I;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; CONGESTIVE HEART FAILURE; FEMALE; HYPERTROPHIC CARDIOMYOPATHY; MALE; PATHOPHYSIOLOGY; STATISTICAL MODEL;

ANIMALS; BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; CAT DISEASES; CATS; FEMALE; HEART FAILURE, CONGESTIVE; LOGISTIC MODELS; MALE; TROPONIN I;

EID: 0042689172     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2002)016<0558:ctiifh>2.3.co;2     Document Type: Article

References (62)

1. Kittleson MD. Hypertrophic cardiomyopathy. In: Kittleson MD. Kienle RD, eds. Small Animal Cardiovascular Medicine. St Louis, MO: Mosby; 1998:347-362.
2. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: A discussion of nomenclature. Am J Cardiol 1979;43.1242-1244.
3. Maron BJ, Gottdiener JS, Epstein SE Patterns and significance of distribution of left ventricular hypertrophy in hypertrophie cardiomyopathy. A wide angle, two-dimensional echocardiographic study of 125 patients Am J Cardiol 1981;48:418-428.
4. Fox PR, Liu SK, Maron BJ. Echocardiographic assessment of spontaneously occurring feline hypertrophie cardiomyopathy. Circulation 1995;92:2645-2651.
5. Peterson EN, Moise NS, Brown CA, et al Heterogeneity of hypertrophy in feline hypertrophie heart disease J Vet Intern Med 1993; 7:183-189.
6. Jacobs JJ. Clinical, morphologic, and diagnostic features of primary feline cardiomyopathies. Vet Med 1996;91:445-459.
7. Behrend EN. Grauer GE Greco DS. Feline hypertrophie cardiomyopathy, part 2. Feline Pract 1997;25:9-12.
8. Atkins CE, Gallo AM, Kurzman ID, Cowen P Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic cardiomyopathy: 74 cases (1985-1989). J Am Vet Med Assoc 1992; 201:613-618.
9. Laste NJ, Harpster NK. A retrospective study of 100 cases of feline distal aortic thromboembolism. 1977-1993. J Am Anim Hosp Assoc 1995;31:492-500.
10. Adams JE, Bodor GS, Davila-Roman, et al. Cardiac troponin I: A marker with high specificity for cardiac injury. Circulation 1993; 88:101-106.
11. Chapelle JP. Cardiac troponin I and troponin T: Recent players in the field of myocardial markers. Clin Chem Lab Med 1999;37:11-20.
12. Lipshultz SE. Rifai N, Sallan SE. et al. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation 1997;96.2641-2648.
13. Dean KJ Biochemistry and molecular biology of troponins I and T. In: Wu AHB. ed. Cardiac Markers. Totowa, NJ: Humana Press, 1998:193-204.
14. Herman EH, Lipshultz SE, Rifai N, et al. Uses of cardiac troponin T levels as an indicator of doxorubicin cardiotoxicity. Cancer Res 1998;58:195-197
15. O'Brien PJ, Dameron GW, Beck ML, et al. Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim Sct 1997;47:486-495.
16. Bodor GS, Porter S, Landt Y, Landenson J. Development of monoclonal antibodies for an assay of cardiac troponin I and preliminary results of suspected cases of myocardial infarction. Clin Chem 1992;30:2203-2214.
17. Martin GS, Becker BN, Schulman G. Cardiac troponin-I accurately predicts myocardial injury in renal failure. Nephrol Dial Transplant 1998;13:1709-1712.
18. Rice MS, MacDonald DC. Appropriate roles of cardiac troponins in evaluating patients with chest pain. J Am Board Fam Pract 1999.12:214-218.
19. Hamm CW, Goldmann BU, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin I or troponin T. N Engl J Med 1997,337:1648-1653.
20. Schober K, Kirbach B, Oechtering G. Myocardial cell injury from traumatic, degenerative, and metabolic heart disease. Proceedings of the 17th Annual Veterinary Medical (ACVIM) Forum, Chicago. IL. 1999:66-67.
21. O'Brien PJ. Landt Y. Landenson J. Differential reactivity of cardiac and skeletal muscle from various species in a cardiac troponin I immunoassay. Clin Chem 1997;43:2333-2338.
22. O'Brien PJ, Dameron GW, Beck ML, Brandt M. Differential reactivity of cardiac and skeletal muscle from various species in two generations of cardiac troponm-T immunoassays. Res Vet Sci 1998; 65:135-137
23. Schober K, Kirbach B, Oechtering G. Noninvasive assessment of myocardial cell injury in dogs with suspected cardiac contusion. Eur J Vet Cardiol 2000;1:17-25.
24. Kirbach B. Schober K, Oechtering G, Aupperle H. Diagnosis of myocardial cell injuries in cats with blunt thoracic trauma using circulating biochemical markers. Tieraerztl Prax 2000;28:30-33.
25. Cornelisse CJ, Schott HC. Olivier NB, et al. Concentration of cardiac troponin I in a horse with a ruptured aortic regurgitation jet lesion and ventricular tachycardia. J Am Vet Med Assoc 2000;217: 231-235.
26. Sribhen C, Kasemsant MLN, Kaewmokul S. Sribhen K. Blood chemistry profile and cardiac troponin T concentration in Thai stray dogs infected with heartworms. Kasetsart J Nat Sci 1999;33:251-257.
27. O'Brien PJ Deficiencies of myocardial troponin-T and creatine kinase MB isoenzyme in dogs with idiopathic dilated cardiomyopathy. Am J Vet Res 1997;58:11-16.
28. Sleeper MM. Clifford CA, Laster LL. Cardiac troponin I in the normal dog and cat. J Vet Intern Med 2001;15:501-503.
29. DeFrancesco TC, Atkins CE, Keene BW. et al. Evaluation of cardiac troponin T as a potential predictor of doxorubicin cardiotoxicity in dogs. J Vet Intern Med 2000;14:335.
30. Schober KE. Circulating cardiac troponins in small animals. Proceedings of the 19th Annual Veterinary Medical (ACVIM) Forum. Denver, CO, May 2001:91-92.
31. Missov E. Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 1997;96:2953-2958.
32. La Vecchia L, Mezzena G. Ometto R. et al. Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin. Am J Cardiol 1997;80:88-89.
33. La Vecchia L, Mezzena G, Zanolla L, et al. Cardiac troponin I as diagnostic and prognostic marker in severe heart failure. J Heart Lung Transplant 2000;19:644-652.
34. Chen YN, Wei JR, Zeng LJ, Wu MY Monitoring of cardiac troponin I in patients with acute heart failure. Ann Clin Biochem 1999; 36:433-437.
35. Del Carlo CH. O'Connor CM. Cardiac troponins in congestive heart failure. Am Heart J 1999;138:646-653.
36. Kittleson MD, Pion PD, Delellis LA, et al. Increased serum growth hormone concentration in feline hypertrophic cardiomyopathy. J Vet Intern Med 1992;6:320-324
37. Golden AL, Bright JM. Use of relaxation half-time as an index of ventricular relaxation in clinically normal cats and cats with hypertrophic cardiomyopathy. Am J Vet Res 1990;51:1352-1356.
38. Bright JM, Golden AL, Gompf RE. et al. Evaluation of the calcium channel-blocking agents diltiazem and verapamil for treatment of feline hypertrophie cardiomyopathy J Vet Intern Med 1991;5:272-282.
39. Scharer K. Schmidt KG, Soergel M. Cardiac function and structure in patients with chronic renal failure. Pediatr Nephrol 1999;13: 951-965
40. Adin DB, Thomas WP, Adin CA, et al. Echocardiographic evaluation of cats with chronic renal failure Proceedings of the 18th Annual Veterinary Medical (ACVIM) Forum, Seattle, WA, 2000 337.
41. ® CS STAT Fluorometric Analyzer. Technical Bulletin. Newark, DE: Dade Behring Inc; 1998.
42. Duncan RJ, Prasse KW, Mahaffey EA. Veterinary Laboratory Medicine. 3rd ed. Ames. IA: Iowa State University Press; 1994.
43. Wu AH, Apple FS, Gibier WB, et al. National Academy of Clinical Biochemistry standards of laboratory practice: Recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999;45:1104-1121.
44. Jaffe AS, Ravkilde J, Roberts R. et al. It's time for a troponin standard. Circulation 2000;102:1216-1220.
45. Liu SK, Roberts WC, Maron BJ. Comparison of morphologic findings in spontaneously occurring hypertrophie cardiomyopathy in humans, cats, and dogs. Am J Cardiol 1993;72:944-951.
46. Maron BJ, Wolfson JK. Epstein SE, et al. Intramural ("small vessel") coronary artery disease in hypertrophie cardiomyopathy. J Am Coll Cardiol 1986;8:545-557.
47. Krams R, Kofflard MJM, Duncker DJ, et al. Decreased coronary flow reserve in hypertrophie cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation 1998;97:230-233.
48. Crowley JJ, Dardas PS, Harcombe AA, et al. Transthoracic doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophie cardiomyopathy. Heart 1997;77:558-563.
49. Cannon RO III, Rosing DR, Maron BJ, et al. Myocardial ischemia in patients with hypertrophie cardiomyopathy: Contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985;71:234-243.
50. Pichard AD, Meller J, Teichholz LE, et al. Septal perforator compression (narrowing) in idiopathic hypertrophie cardiomyopathy. Am J Cardiol 1977;40:310-4.
51. Packer M. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure J Am Coll Cardiol 1992;20:248-254.
52. Mancia G. Neurohormonal activation in congestive heart failure. Am Heart J 1990,120:1532-1537.
53. Pedersen HD, Koch J, Poulson K, et al. Activation of the reninangiotensin system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency. J Vet Intern Med 1995;9:328-331.
54. Koch J, Pedersen HD, Jensen AL, et al. Activation of the reninangiotensin system in dogs with asymptomatic and symptomatic dilated cardiomyopathy. Res Vet Sci 1995;59:172-175.
55. Pedersen HD, Mow T. Hypomagnesemia and mitral valve prolapse in Cavalier King Charles Spaniels. J Vet Med Ser A 1998;45: 607-614.
56. Ware WA, Lund DD, Subieta AR. et al. Sympathetic activation in dogs with congestive heart failure caused by chronic mitral valve disease and dilated cardiomyopathy. J Am Vet Med Assoc 1990;197: 1475-1481.
57. Haggstrom J, Hansson K, Kvart C, et al. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs. Am J Vet Res 1997;58:77-82.
58. Apple FS. Clinical and analytical standardization issues confronting cardiac troponin I. Clin Chem 1999;45:18-20.
59. Katrukha AG, Bereznikova AV, Filatov VL, et al. Degradation of cardiac troponin I' Implication for reliable immunodetection. Clin Chem 1998;44:2433-2440.
60. Giannitsis E, Muller-Bardorff M, Kurowski V, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000;102:211-217
61. Fernandes CJ, Akamme N. Knobel E Cardiac troponin: A new serum marker of myocardial injury in sepsis. Intensive Care Med 1999;10:1165-1168.
62. Kittleson MD, Meurs KM, Munro MJ, et al. Familial hypertrophic cardiomyopathy in Maine Coon Cats. An animal model of human disease. Circulation 1999;3172-3180.